Temozolomid med eller uden capecitabin til behandling af patienter med avancerede pancreas neuroendokrine tumorer
Et randomiseret fase II-studie af temozolomid eller temozolomid og capecitabin hos patienter med avancerede pancreas neuroendokrine tumorer
This randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors. Drugs used in chemotherapy, such as temozolomide and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether temozolomide is more effective with or without capecitabine in treating patients with advanced pancreatic neuroendocrine tumors.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
PRIMARY OBJECTIVES:
I. To evaluate progression-free survival (PFS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
SECONDARY OBJECTIVES:
I. To evaluate response rates (RR) associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
II. To evaluate overall survival (OS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
III. To evaluate the toxicity associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
IV. To evaluate the usefulness of methyl guanine methyltransferase (MGMT) status (by immunohistochemistry [IHC] and promoter methylation) for predicting response in pancreatic neuroendocrine tumor patients treated with either temozolomide or temozolomide and capecitabine.
V. To bank radiology images for evaluation of quality, reproducibility, and compliance with computed tomography (CT) methodology.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM A: Patients receive temozolomide orally (PO) once daily (QD) on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
ARM B: Patients receive capecitabine PO twice daily (BID) on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for 2 years, and then every 6 months for 3 years.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Fase 2
Kontakter og lokationer
Studiesteder
-
-
California
-
Anaheim, California, Forenede Stater, 92807
- Kaiser Anaheim Medical Center
-
Antioch, California, Forenede Stater, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Baldwin Park, California, Forenede Stater, 91706
- Kaiser Permanente Medical Group - Baldwin Park
-
Bellflower, California, Forenede Stater, 90706
- Kaiser Foundation Hospital
-
Berkeley, California, Forenede Stater, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Burlingame, California, Forenede Stater, 94010
- Mills - Peninsula Hospitals
-
Fontana, California, Forenede Stater, 92335
- Kaiser Permanente Hospital
-
Fremont, California, Forenede Stater, 94538
- Kaiser Permanente, Fremont
-
Fresno, California, Forenede Stater, 93720
- Kaiser Permanente
-
Harbor City, California, Forenede Stater, 90710
- Kaiser Permanente - Harbor City
-
Hayward, California, Forenede Stater, 94545
- Kaiser Permanente, Hayward
-
Irvine, California, Forenede Stater, 92618
- Southern California Permanente Medical Group
-
Los Angeles, California, Forenede Stater, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, Forenede Stater, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, Forenede Stater, 90033
- University of Southern California/Norris Cancer Center
-
Los Angeles, California, Forenede Stater, 90034
- Kaiser Permanente-West Los Angeles
-
Modesto, California, Forenede Stater, 95356
- Kaiser Permanente-Modesto
-
Novato, California, Forenede Stater, 94945
- Sutter Cancer Research Consortium
-
Oakland, California, Forenede Stater, 94611
- Kaiser Permanente-Oakland
-
Orange, California, Forenede Stater, 92868
- University of California Medical Center At Irvine-Orange Campus
-
Panorama City, California, Forenede Stater, 91402
- Kaiser Permanente - Panorama City
-
Redwood City, California, Forenede Stater, 94063
- Kaiser Permanente-Redwood City
-
Richmond, California, Forenede Stater, 94801
- Kaiser Permanente-Richmond
-
Riverside, California, Forenede Stater, 92505
- Kaiser Permanente Medical Center
-
Roseville, California, Forenede Stater, 95661
- Kaiser Permanente-Roseville
-
Sacramento, California, Forenede Stater, 95823
- Kaiser Permanente-South Sacramento
-
Sacramento, California, Forenede Stater, 95825
- Kaiser Permanente - Sacramento
-
San Diego, California, Forenede Stater, 92120
- Kaiser Permanente at San Diego
-
San Diego, California, Forenede Stater, 92120
- Kaiser Permanente
-
San Francisco, California, Forenede Stater, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, Forenede Stater, 94118
- California Pacific Medical Center
-
San Francisco, California, Forenede Stater, 94115
- UCSF-Mount Zion
-
San Jose, California, Forenede Stater, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Marcos, California, Forenede Stater, 92069
- Kaiser Permanente Health Care
-
San Rafael, California, Forenede Stater, 94903
- Kaiser Permanente-San Rafael
-
Santa Clara, California, Forenede Stater, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, Forenede Stater, 95403
- Kaiser Permanente-Santa Rosa
-
Santa Rosa, California, Forenede Stater, 95403
- Sutter Pacific Medical Foundation
-
South San Francisco, California, Forenede Stater, 94080
- Kaiser Permanente-South San Francisco
-
Stanford, California, Forenede Stater, 94305
- Stanford University Hospitals and Clinics
-
Stockton, California, Forenede Stater, 95210
- Kaiser Permanente-Stockton
-
Vacaville, California, Forenede Stater, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Forenede Stater, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, Forenede Stater, 94589
- Sutter Solano Medical Center
-
Walnut Creek, California, Forenede Stater, 94596
- Kaiser Permanente-Walnut Creek
-
Woodland Hills, California, Forenede Stater, 91367
- Kaiser Permanente
-
-
Connecticut
-
Hartford, Connecticut, Forenede Stater, 06105
- Saint Francis Hospital and Medical Center
-
Middletown, Connecticut, Forenede Stater, 06457
- Middlesex Hospital
-
-
Delaware
-
Lewes, Delaware, Forenede Stater, 19958
- Beebe Medical Center
-
Newark, Delaware, Forenede Stater, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Forenede Stater, 19713
- Delaware Clinical and Laboratory Physicians PA
-
Newark, Delaware, Forenede Stater, 19713
- Medical Oncology Hematology Consultants PA
-
Newark, Delaware, Forenede Stater, 19718
- Christiana Care Health System-Christiana Hospital
-
Newark, Delaware, Forenede Stater, 19713
- Christiana Gynecologic Oncology LLC
-
Newark, Delaware, Forenede Stater, 19713
- Regional Hematology and Oncology PA
-
Rehoboth Beach, Delaware, Forenede Stater, 19971
- Beebe Health Campus
-
Seaford, Delaware, Forenede Stater, 19973
- Nanticoke Memorial Hospital
-
Wilmington, Delaware, Forenede Stater, 19801
- Christiana Care Health System-Wilmington Hospital
-
-
Florida
-
Jacksonville, Florida, Forenede Stater, 32207
- Edna Williams Cancer Center at the Baptist Cancer Institute
-
Miami, Florida, Forenede Stater, 33136
- University of Miami Miller School of Medicine-Sylvester Cancer Center
-
Orlando, Florida, Forenede Stater, 32803
- Florida Hospital
-
Tampa, Florida, Forenede Stater, 33612
- H. Lee Moffitt Cancer Center and Research Institute
-
-
Hawaii
-
Honolulu, Hawaii, Forenede Stater, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Forenede Stater, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Forenede Stater, 96819
- Kaiser Permanente Moanalua Medical Center
-
Honolulu, Hawaii, Forenede Stater, 96813
- University of Hawaii
-
Honolulu, Hawaii, Forenede Stater, 96813
- Oncare Hawaii Inc-POB II
-
Honolulu, Hawaii, Forenede Stater, 96817-3169
- OnCare Hawaii-Liliha
-
Honolulu, Hawaii, Forenede Stater, 96817
- Oncare Hawaii Inc-Kuakini
-
Kailua, Hawaii, Forenede Stater, 96734
- Castle Medical Center
-
Lihue, Hawaii, Forenede Stater, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, Forenede Stater, 96701
- Pali Momi Medical Center
-
‘Aiea, Hawaii, Forenede Stater, 96701
- Oncare Hawaii Inc-Pali Momi
-
-
Idaho
-
Boise, Idaho, Forenede Stater, 83706
- Saint Alphonsus Regional Medical Center
-
-
Illinois
-
Bloomington, Illinois, Forenede Stater, 61701
- Saint Joseph Medical Center
-
Bloomington, Illinois, Forenede Stater, 61701
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Forenede Stater, 61520
- Illinois CancerCare-Canton
-
Carbondale, Illinois, Forenede Stater, 62902
- Memorial Hospital of Carbondale
-
Carthage, Illinois, Forenede Stater, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Forenede Stater, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Forenede Stater, 60611
- Northwestern University
-
Chicago, Illinois, Forenede Stater, 60612
- University of Illinois
-
Decatur, Illinois, Forenede Stater, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Forenede Stater, 62526
- Cancer Care Center of Decatur
-
Effingham, Illinois, Forenede Stater, 62401
- Crossroads Cancer Center
-
Eureka, Illinois, Forenede Stater, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Forenede Stater, 61401
- Illinois CancerCare Galesburg
-
Galesburg, Illinois, Forenede Stater, 61401
- Illinois CancerCare-Galesburg Cottage Plaza Office
-
Highland Park, Illinois, Forenede Stater, 60035
- Hematology Oncology Associates of Illinois-Highland Park
-
Hinsdale, Illinois, Forenede Stater, 60521
- Hinsdale Hematology Oncology Associates Incorporated
-
Kankakee, Illinois, Forenede Stater, 60901
- Presence Saint Mary's Hospital
-
Kewanee, Illinois, Forenede Stater, 61443
- Illinois CancerCare-Kewanee Clinic
-
Libertyville, Illinois, Forenede Stater, 60048
- North Shore Hematology Oncology
-
Macomb, Illinois, Forenede Stater, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, Forenede Stater, 60153
- Loyola University Medical Center
-
Moline, Illinois, Forenede Stater, 61265
- Garneau, Stewart C MD (UIA Investigator)
-
Moline, Illinois, Forenede Stater, 61265
- Porubcin, Michael MD (UIA Investigator)
-
Moline, Illinois, Forenede Stater, 61265
- Spector, David MD (UIA Investigator)
-
Moline, Illinois, Forenede Stater, 61265
- Trinity Medical Center
-
Monmouth, Illinois, Forenede Stater, 61462
- Illinois CancerCare-Monmouth
-
Mount Vernon, Illinois, Forenede Stater, 62864
- Good Samaritan Regional Health Center
-
Niles, Illinois, Forenede Stater, 60714
- Illinois Cancer Specialists-Niles
-
Normal, Illinois, Forenede Stater, 61761
- Community Cancer Center Foundation
-
Ottawa, Illinois, Forenede Stater, 61350
- Illinois CancerCare-Ottawa Clinic
-
Ottawa, Illinois, Forenede Stater, 61350
- Ottawa Regional Hospital and Healthcare Center
-
Pekin, Illinois, Forenede Stater, 61554
- Pekin Cancer Treatment Center
-
Pekin, Illinois, Forenede Stater, 61603
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Forenede Stater, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, Forenede Stater, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, Forenede Stater, 61614
- Proctor Hospital
-
Peoria, Illinois, Forenede Stater, 61603
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Forenede Stater, 61615
- Illinois Oncology Research Association CCOP
-
Peru, Illinois, Forenede Stater, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Forenede Stater, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, Forenede Stater, 61107
- SwedishAmerican Regional Cancer Center/ACT
-
Skokie, Illinois, Forenede Stater, 60076
- Hematology Oncology Associates of Illinois - Skokie
-
Springfield, Illinois, Forenede Stater, 62781-0001
- Memorial Medical Center
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater, 46237
- Franciscan Saint Francis Health-Indianapolis
-
Richmond, Indiana, Forenede Stater, 47374
- Reid Hospital and Health Care Services
-
-
Iowa
-
Ames, Iowa, Forenede Stater, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Forenede Stater, 50010
- McFarland Clinic PC-William R Bliss Cancer Center
-
Bettendorf, Iowa, Forenede Stater, 52722
- Constantinou, Costas L MD (UIA Investigator)
-
Boone, Iowa, Forenede Stater, 50036
- McFarland Clinic PC-Boone
-
Clive, Iowa, Forenede Stater, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Forenede Stater, 50325
- Medical Oncology and Hematology Associates-West Des Moines
-
Des Moines, Iowa, Forenede Stater, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Forenede Stater, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Forenede Stater, 50309
- Medical Oncology and Hematology Associates-Des Moines
-
Des Moines, Iowa, Forenede Stater, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Forenede Stater, 50314
- Medical Oncology and Hematology Associates-Laurel
-
Des Moines, Iowa, Forenede Stater, 50309
- Iowa Oncology Research Association CCOP
-
Jefferson, Iowa, Forenede Stater, 50129
- McFarland Clinic PC-Jefferson
-
Marshalltown, Iowa, Forenede Stater, 50158
- McFarland Clinic PC-Marshalltown
-
Sioux City, Iowa, Forenede Stater, 51104
- Saint Luke's Regional Medical Center
-
Sioux City, Iowa, Forenede Stater, 51101
- Siouxland Hematology Oncology Associates
-
Sioux City, Iowa, Forenede Stater, 51104
- Mercy Medical Center-Sioux City
-
West Des Moines, Iowa, Forenede Stater, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Forenede Stater, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Chanute, Kansas, Forenede Stater, 66720
- Cancer Center of Kansas - Chanute
-
Dodge City, Kansas, Forenede Stater, 67801
- Cancer Center of Kansas - Dodge City
-
El Dorado, Kansas, Forenede Stater, 67042
- Cancer Center of Kansas - El Dorado
-
Fort Scott, Kansas, Forenede Stater, 66701
- Cancer Center of Kansas - Fort Scott
-
Independence, Kansas, Forenede Stater, 67301
- Cancer Center of Kansas-Independence
-
Kingman, Kansas, Forenede Stater, 67068
- Cancer Center of Kansas-Kingman
-
Lawrence, Kansas, Forenede Stater, 66044
- Lawrence Memorial Hospital
-
Liberal, Kansas, Forenede Stater, 67901
- Cancer Center of Kansas-Liberal
-
Manhattan, Kansas, Forenede Stater, 66502
- Cancer Center of Kansas-Manhattan
-
McPherson, Kansas, Forenede Stater, 67460
- Cancer Center of Kansas - McPherson
-
Newton, Kansas, Forenede Stater, 67114
- Cancer Center of Kansas - Newton
-
Parsons, Kansas, Forenede Stater, 67357
- Cancer Center of Kansas - Parsons
-
Pratt, Kansas, Forenede Stater, 67124
- Cancer Center of Kansas - Pratt
-
Salina, Kansas, Forenede Stater, 67401
- Cancer Center of Kansas - Salina
-
Wellington, Kansas, Forenede Stater, 67152
- Cancer Center of Kansas - Wellington
-
Wichita, Kansas, Forenede Stater, 67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita, Kansas, Forenede Stater, 67208
- Associates In Womens Health
-
Wichita, Kansas, Forenede Stater, 67214
- Cancer Center of Kansas - Main Office
-
Wichita, Kansas, Forenede Stater, 67214
- Via Christi Regional Medical Center
-
Wichita, Kansas, Forenede Stater, 67214
- Wichita CCOP
-
Winfield, Kansas, Forenede Stater, 67156
- Cancer Center of Kansas - Winfield
-
-
Kentucky
-
Crestview Hills, Kentucky, Forenede Stater, 41017
- Oncology Hematology Care Incorporated
-
-
Louisiana
-
Baton Rouge, Louisiana, Forenede Stater, 70809
- Ochsner Health Center-Summa
-
New Orleans, Louisiana, Forenede Stater, 70121
- Ochsner Medical Center Jefferson
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02118
- Boston Medical Center
-
Burlington, Massachusetts, Forenede Stater, 01805
- Lahey Hospital and Medical Center
-
-
Michigan
-
Adrian, Michigan, Forenede Stater, 49221
- Bixby Medical Center
-
Adrian, Michigan, Forenede Stater, 49221
- Hickman Cancer Center
-
Ann Arbor, Michigan, Forenede Stater, 48106-0995
- Saint Joseph Mercy Hospital
-
Ann Arbor, Michigan, Forenede Stater, 48106
- Michigan Cancer Research Consortium Community Clinical Oncology Program
-
Ann Arbor, Michigan, Forenede Stater, 48109
- University of Michigan University Hospital
-
Dearborn, Michigan, Forenede Stater, 48124
- Oakwood Hospital
-
Detroit, Michigan, Forenede Stater, 48236
- Saint John Hospital and Medical Center
-
Flint, Michigan, Forenede Stater, 48502
- Hurley Medical Center
-
Flint, Michigan, Forenede Stater, 48503
- Genesys Hurley Cancer Institute
-
Jackson, Michigan, Forenede Stater, 49201
- Allegiance Health
-
Kalamazoo, Michigan, Forenede Stater, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Forenede Stater, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Forenede Stater, 49001
- Borgess Medical Center
-
Lansing, Michigan, Forenede Stater, 48912
- Sparrow Hospital
-
Livonia, Michigan, Forenede Stater, 48154
- Saint Mary Mercy Hospital
-
Monroe, Michigan, Forenede Stater, 48162
- Mercy Memorial Hospital
-
Monroe, Michigan, Forenede Stater, 48162
- Community Cancer Center of Monroe
-
Pontiac, Michigan, Forenede Stater, 48341-2985
- Saint Joseph Mercy Oakland
-
Port Huron, Michigan, Forenede Stater, 48060
- Saint Joseph Mercy Port Huron
-
Saginaw, Michigan, Forenede Stater, 48601
- Saint Mary's of Michigan
-
Warren, Michigan, Forenede Stater, 48093
- Saint John Macomb-Oakland Hospital
-
-
Minnesota
-
Burnsville, Minnesota, Forenede Stater, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, Forenede Stater, 55433
- Mercy Hospital
-
Edina, Minnesota, Forenede Stater, 55435
- Fairview-Southdale Hospital
-
Fridley, Minnesota, Forenede Stater, 55432
- Unity Hospital
-
Hutchinson, Minnesota, Forenede Stater, 55350
- Hutchinson Area Health Care
-
Maplewood, Minnesota, Forenede Stater, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Forenede Stater, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Forenede Stater, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Forenede Stater, 55407
- Abbott-Northwestern Hospital
-
New Ulm, Minnesota, Forenede Stater, 56073
- New Ulm Medical Center
-
Robbinsdale, Minnesota, Forenede Stater, 55422
- North Memorial Medical Health Center
-
Saint Louis Park, Minnesota, Forenede Stater, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park, Minnesota, Forenede Stater, 55416
- Metro-Minnesota CCOP
-
Saint Paul, Minnesota, Forenede Stater, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Forenede Stater, 55102
- United Hospital
-
Shakopee, Minnesota, Forenede Stater, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Forenede Stater, 55082
- Lakeview Hospital
-
Waconia, Minnesota, Forenede Stater, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Forenede Stater, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Forenede Stater, 55125
- Minnesota Oncology and Hematology PA-Woodbury
-
-
Missouri
-
Bolivar, Missouri, Forenede Stater, 65613
- Central Care Cancer Center-Carrie J Babb Cancer Center
-
Branson, Missouri, Forenede Stater, 65616
- CoxHealth Cancer Center
-
Cape Girardeau, Missouri, Forenede Stater, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Forenede Stater, 63703
- Southeast Cancer Center
-
Jefferson City, Missouri, Forenede Stater, 65109
- Capital Region Medical Center-Goldschmidt Cancer Center
-
Rolla, Missouri, Forenede Stater, 65401
- Phelps County Regional Medical Center
-
Rolla, Missouri, Forenede Stater, 65401
- Saint John's Clinic-Rolla-Cancer and Hematology
-
Springfield, Missouri, Forenede Stater, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Forenede Stater, 65804
- Mercy Hospital Springfield
-
Springfield, Missouri, Forenede Stater, 65802
- Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
-
St Louis, Missouri, Forenede Stater, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Forenede Stater, 63109
- Saint Louis Cancer and Breast Institute-South City
-
St Louis, Missouri, Forenede Stater, 63141
- Saint John's Mercy Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Forenede Stater, 68114
- Nebraska Methodist Hospital
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 89106
- Nevada Cancer Research Foundation CCOP
-
-
New Jersey
-
Camden, New Jersey, Forenede Stater, 08103
- Cooper Hospital University Medical Center
-
Mount Holly, New Jersey, Forenede Stater, 08060
- Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County
-
Voorhees Township, New Jersey, Forenede Stater, 08043
- Virtua West Jersey Hospital Voorhees
-
-
New York
-
Albany, New York, Forenede Stater, 12208
- New York Oncology Hematology PC -Albany Medical Center
-
Albany, New York, Forenede Stater, 12206
- New York Oncology Hematology PC - Albany
-
Amsterdam, New York, Forenede Stater, 12010
- New York Oncology Hematology PC - Amsterdam
-
Hudson, New York, Forenede Stater, 12534
- New York Oncology Hematology PC-Hudson
-
Latham, New York, Forenede Stater, 12110
- New York Oncology Hematology PC - Latham
-
Rexford, New York, Forenede Stater, 12148
- New York Oncology Hematology PC - Rexford
-
Rochester, New York, Forenede Stater, 14642
- University of Rochester
-
The Bronx, New York, Forenede Stater, 10467-2490
- Montefiore Medical Center
-
The Bronx, New York, Forenede Stater, 10461
- Montefiore Medical Center-Weiler Division
-
Troy, New York, Forenede Stater, 12180
- New York Oncology Hematology PC - Troy
-
-
North Carolina
-
Kinston, North Carolina, Forenede Stater, 28501
- Kinston Medical Specialists PA
-
Statesville, North Carolina, Forenede Stater, 28677
- Iredell Memorial Hospital
-
-
Ohio
-
Akron, Ohio, Forenede Stater, 44307
- Akron General Medical Center
-
Beachwood, Ohio, Forenede Stater, 44122
- Cleveland Clinic Cancer Center Beachwood
-
Belpre, Ohio, Forenede Stater, 45714
- Strecker Cancer Center-Belpre
-
Bowling Green, Ohio, Forenede Stater, 43402
- Toledo Clinic Cancer Centers-Bowling Green
-
Chillicothe, Ohio, Forenede Stater, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Forenede Stater, 45267
- University of Cincinnati
-
Cincinnati, Ohio, Forenede Stater, 45230
- Oncology Hematology Care Inc - Anderson
-
Cincinnati, Ohio, Forenede Stater, 45236
- Oncology Hematology Care Inc - Kenwood
-
Cincinnati, Ohio, Forenede Stater, 45219
- Oncology and Hematology Care Incorporated
-
Cincinnati, Ohio, Forenede Stater, 45242
- Oncology and Hematology Care Inc - Blue Ash
-
Cincinnati, Ohio, Forenede Stater, 45248
- Oncology Hematology Care Inc - Western Hills
-
Cleveland, Ohio, Forenede Stater, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Forenede Stater, 44195
- Cleveland Clinic Foundation
-
Columbus, Ohio, Forenede Stater, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Forenede Stater, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Forenede Stater, 43210
- Ohio State University Medical Center
-
Columbus, Ohio, Forenede Stater, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, Forenede Stater, 43228
- Doctors Hospital
-
Columbus, Ohio, Forenede Stater, 43215
- Grant Medical Center
-
Columbus, Ohio, Forenede Stater, 43222
- Mount Carmel Health Center West
-
Columbus, Ohio, Forenede Stater, 43215
- Columbus CCOP
-
Dayton, Ohio, Forenede Stater, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, Forenede Stater, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Forenede Stater, 45415
- Samaritan North Health Center
-
Dayton, Ohio, Forenede Stater, 45405
- Grandview Hospital
-
Dayton, Ohio, Forenede Stater, 45420
- Dayton CCOP
-
Delaware, Ohio, Forenede Stater, 43015
- Delaware Health Center-Grady Cancer Center
-
Delaware, Ohio, Forenede Stater, 43015
- Delaware Radiation Oncology
-
Delaware, Ohio, Forenede Stater, 43015
- Grady Memorial Hospital
-
Elyria, Ohio, Forenede Stater, 44035
- Mercy Cancer Center-Elyria
-
Elyria, Ohio, Forenede Stater, 44035
- Hematology Oncology Center Incorporated
-
Fairfield, Ohio, Forenede Stater, 45014
- Oncology Hematology Care Inc
-
Findlay, Ohio, Forenede Stater, 45840
- Blanchard Valley Hospital
-
Franklin, Ohio, Forenede Stater, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville, Ohio, Forenede Stater, 45331
- Wayne Hospital
-
Independence, Ohio, Forenede Stater, 44131
- Cleveland Clinic Cancer Center Independence
-
Kettering, Ohio, Forenede Stater, 45429
- Kettering Medical Center
-
Lancaster, Ohio, Forenede Stater, 43130
- Fairfield Medical Center
-
Lancaster, Ohio, Forenede Stater, 43130
- Lancaster Radiation Oncology
-
Lima, Ohio, Forenede Stater, 45801
- Saint Rita's Medical Center
-
Lima, Ohio, Forenede Stater, 45804
- Lima Memorial Hospital
-
Marietta, Ohio, Forenede Stater, 45750
- Marietta Memorial Hospital
-
Maumee, Ohio, Forenede Stater, 43537
- Toledo Clinic Cancer Centers-Maumee
-
Maumee, Ohio, Forenede Stater, 43537
- Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
-
Mayfield Heights, Ohio, Forenede Stater, 44124
- Hillcrest Hospital Cancer Center
-
Mount Vernon, Ohio, Forenede Stater, 43050
- Knox Community Hospital
-
Newark, Ohio, Forenede Stater, 43055
- Licking Memorial Hospital
-
Newark, Ohio, Forenede Stater, 43055
- Newark Radiation Oncology
-
Oregon, Ohio, Forenede Stater, 43616
- Saint Charles Hospital
-
Oregon, Ohio, Forenede Stater, 43616
- Toledo Clinic Cancer Centers-Oregon
-
Portsmouth, Ohio, Forenede Stater, 45662
- Southern Ohio Medical Center
-
Sandusky, Ohio, Forenede Stater, 44870
- North Coast Cancer Care
-
Springfield, Ohio, Forenede Stater, 45505
- Springfield Regional Medical Center
-
Strongsville, Ohio, Forenede Stater, 44136
- Cleveland Clinic Cancer Center-Strongsville
-
Sylvania, Ohio, Forenede Stater, 43560
- Flower Hospital
-
Tiffin, Ohio, Forenede Stater, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, Forenede Stater, 43608
- Saint Vincent Mercy Medical Center
-
Toledo, Ohio, Forenede Stater, 43623
- Toledo Clinic Cancer Centers-Toledo
-
Toledo, Ohio, Forenede Stater, 43614
- University of Toledo
-
Toledo, Ohio, Forenede Stater, 43617
- Toledo Community Hospital Oncology Program CCOP
-
Toledo, Ohio, Forenede Stater, 43606
- The Toledo Hospital/Toledo Children's Hospital
-
Toledo, Ohio, Forenede Stater, 43623
- Mercy Saint Anne Hospital
-
Troy, Ohio, Forenede Stater, 45373
- Upper Valley Medical Center
-
Wauseon, Ohio, Forenede Stater, 43567
- Fulton County Health Center
-
Westerville, Ohio, Forenede Stater, 43081
- Saint Ann's Hospital
-
Xenia, Ohio, Forenede Stater, 45385
- Greene Memorial Hospital
-
Zanesville, Ohio, Forenede Stater, 43701
- Genesis HealthCare System
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Forenede Stater, 74146
- Tulsa Cancer Institute
-
-
Pennsylvania
-
Danville, Pennsylvania, Forenede Stater, 17822-2001
- Geisinger Medical Center
-
Hazleton, Pennsylvania, Forenede Stater, 18201
- Geisinger Medical Center-Cancer Center Hazleton
-
Hershey, Pennsylvania, Forenede Stater, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Lewisburg, Pennsylvania, Forenede Stater, 17837
- Geisinger Medical Oncology at Evangelical Community Hospital
-
Philadelphia, Pennsylvania, Forenede Stater, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Forenede Stater, 19107
- Thomas Jefferson University Hospital
-
Pottsville, Pennsylvania, Forenede Stater, 17901
- Geisinger Medical Oncology-Pottsville
-
State College, Pennsylvania, Forenede Stater, 16801
- Geisinger Medical Group
-
West Reading, Pennsylvania, Forenede Stater, 19611
- Reading Hospital
-
Wilkes-Barre, Pennsylvania, Forenede Stater, 18711
- Geisinger Wyoming Valley
-
-
South Carolina
-
Greenville, South Carolina, Forenede Stater, 29605
- Greenville Health System Cancer Institute-Butternut
-
Greenville, South Carolina, Forenede Stater, 29615
- Greenville Health System Cancer Institute/Greenville CCOP
-
Greer, South Carolina, Forenede Stater, 29650
- Greenville Health System Cancer Institute-Greer
-
-
Tennessee
-
Nashville, Tennessee, Forenede Stater, 37232-6838
- Vanderbilt Cancer Center
-
-
Virginia
-
Fredericksburg, Virginia, Forenede Stater, 22401
- Fredericksburg Oncology Inc
-
-
Wisconsin
-
La Crosse, Wisconsin, Forenede Stater, 54601
- Gundersen Lutheran
-
Madison, Wisconsin, Forenede Stater, 53792
- University of Wisconsin Hospital and Clinics
-
Milwaukee, Wisconsin, Forenede Stater, 53226
- Froedtert and the Medical College of Wisconsin
-
New Richmond, Wisconsin, Forenede Stater, 54017
- Cancer Center of Western Wisconsin
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-
Patient must have histologically or pathologically confirmed locally unresectable or metastatic low or intermediate grade pancreatic neuroendocrine tumor
-
Patient must have measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria; baseline measurements and evaluations of all sites of disease must be obtained <= 4 weeks prior to randomization and must be acquired by multiphasic CT or contrast magnetic resonance imaging (MRI)
-
Date of last documented disease progression must be within 12 months from date of randomization
-
Prior everolimus and/or sunitinib therapy is allowed, so long as it was discontinued >= 4 weeks prior to randomization
-
Concurrent somatostatin analogues are allowed provided that patients
- Have been on a stable dose for 8 weeks and
- Have documented disease progression on that dose
-
Chemoembolization is allowed if ≥ 4 weeks from study entry. There are 2 possible scenarios:
- If patient has hepatic disease only: they need to have progressed in the liver since chemoembolization and have measurable disease by RECIST 1.1 in order to be eligible.
- If patient has hepatic and extrahepatic disease: they will need to have progressed inside OR outside the liver and have measureable disease by RECIST 1.1 in order to be eligible.
-
Leukocytes >= 3,000/mm^3
-
Absolute neutrophil count >= 1,500/mm^3
-
Hemoglobin >= 9 g/dL
-
Platelets >= 100,000/mm^3
-
Total bilirubin <= institutional upper limit of normal (ULN) or <= 1.5 X institutional ULN (if the patient has liver metastases)
-
Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) <= 3 X institutional ULN or (<= 5 X institutional ULN if the patient has liver metastases)
-
Serum creatinine <= 1.5 X institutional ULN
-
Patient must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1
-
Patient must have life expectancy >= 12 weeks all females of childbearing potential must have a blood test or urine study within =< 2 weeks prior to randomization to rule out pregnancy; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:
- Has not undergone a hysterectomy or bilateral oophorectomy; or
- Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
-
Women of childbearing potential and sexually active males must be strongly advised to use an accepted and effective method of contraception or to abstain from sexual intercourse for the duration of their participation in the study; should a woman become pregnant while participating in this study, she should inform her treating physician immediately; if a man impregnates a woman while participating in this study, he should inform his treating physician immediately
-
Patient must be able to swallow pills
-
Patient must be able to tolerate CT or magnetic resonance (MR) imaging including contrast agents as required for their treatment and the protocol
Exclusion Criteria:
-
Small cell carcinoma
-
Prior temozolomide, dacarbazine (DTIC), or capecitabine, or 5-FU (fluorouracil) therapy
-
Receiving any other investigational agents while on study treatment
-
Receiving Coumadin while on treatment; other anticoagulants are allowed
-
Patients with either clinically apparent central nervous system metastases or carcinomatous meningitis are ineligible
-
Active or uncontrolled infection or serious medical or psychiatric illness
-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide or capecitabine
-
Absorption issues that would limit the ability to absorb study agents
-
Patients with a history of the following within 12 months of study entry:
- Arterial thromboembolic events
- Unstable angina
- Myocardial Infarction
-
Symptomatic peripheral vascular disease
-
Patients with previous or concurrent malignancy; exceptions are made for patients who meet any of the following conditions:
- Non-melanoma skin cancer, in situ cervical cancer, or breast cancer in situ OR
- Prior malignancy completely excised or removed and patient has been continuously disease free for > 5 years OR
- Prior malignancy cured by non-surgical modalities and patient has been continuously disease free for > 5 years
-
Pregnant or breast-feeding
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Arm A (temozolomide)
Patients receive temozolomide PO QD on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Andre navne:
|
|
Eksperimentel: Arm B (temozolomide and capecitabine)
Patients receive capecitabine PO BID on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Andre navne:
Given PO
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Progression-free Survival
Tidsramme: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Progression-free survival (PFS) is defined as the time from randomization to progression or death without evidence of progression. Progression was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of at least 5 mm. Kaplan-Meier method was used to estimate PFS. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of Patients With Response
Tidsramme: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Overall Survival
Tidsramme: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Overall survival is defined as time from randomization to death or date last known alive. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Immunohistochemistry (IHC) and Response
Tidsramme: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status was determined by IHC using paraffin-embedded sections of 4µm. A score (H-score) was generated based on the findings and scoring was performed by two pathologists. This H-score ranges from 0 (no staining in the tumor) to 300 (diffuse intense staining of the tumor). The highest score was used if there was disagreement. H-scores were grouped into 3 standard categories for MGMT status: Category 1 - <=50 Category 2 - 51-100 Category 3 - >100 |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Promoter Methylation and Response
Tidsramme: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status is determined by promoter methylation, a clinically validated methylation-specific polymerase chain reaction (PCR) analysis. A tumor sample is considered positive for MGMT promoter methylation if an 80bp band is detected in the methylated PCR reaction. It would be considered MGMT negative if an 80bp band is not detected in the methylated PCR reaction. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Pamela Kunz, ECOG-ACRIN Cancer Research Group
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Anslået)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Sygdomme i det endokrine system
- Neoplasmer efter sted
- Neoplasmer
- Neoplasmer efter histologisk type
- Neoplasmer i fordøjelsessystemet
- Sygdomme i fordøjelsessystemet
- Neoplasmer i endokrine kirtler
- Pancreassygdomme
- Neoplasmer, kirtel og epitel
- Adenocarcinom
- Adenom
- Karcinom
- Neuroektodermale tumorer
- Neoplasmer, kimceller og embryonale
- Neuroendokrine tumorer
- Karcinom, neuroendokrin
- Bugspytkirtel neoplasmer
- Adenom, øcelle
- Karcinom, øcelle
- Gastrinom
- Insulinom
- Glukagonom
- Somatostatinom
- Organiske kemikalier
- Heterocykliske forbindelser, 1-ring
- Heterocykliske forbindelser
- Azoler
- Nukleinsyrer, nukleotider og nukleosider
- Dacarbazine
- Triazener
- Imidazoler
- Deoxycytidin
- Cytidin
- Pyrimidin -nukleosider
- Pyrimidiner
- Nukleosider
- Uracil
- Pyrimidinoner
- Deoxyribonucleosider
- Fluorouracil
- Temozolomid
- Capecitabin
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- E2211
- U10CA180820 (U.S. NIH-bevilling/kontrakt)
- U10CA021115 (U.S. NIH-bevilling/kontrakt)
- E2211 (Anden identifikator: ECOG-ACRIN Cancer Research Group)
- NCI-2012-02007 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .